Randomized controlled trials of Chinese herbal medicine published in English from 2010 to 2019: a bibliometrics study
| العنوان: | Randomized controlled trials of Chinese herbal medicine published in English from 2010 to 2019: a bibliometrics study |
|---|---|
| المؤلفون: | Rui Zhang, Xue-Jiao Wang, Yanxiang Ha, Bo Li, Hui-Na Zhang, Shuo Feng, Jing Hu, Chong-Yang Wei |
| المصدر: | Annals of Palliative Medicine. 10:12945-12954 |
| بيانات النشر: | AME Publishing Company, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Advanced and Specialized Nursing, medicine.medical_specialty, business.industry, MEDLINE, Traditional Chinese medicine, Cochrane Library, Bibliometrics, Placebo, law.invention, Anesthesiology and Pain Medicine, Quality of life, Randomized controlled trial, Research Design, law, Family medicine, Humans, Medicine, Integrative medicine, Medicine, Chinese Traditional, business, Drugs, Chinese Herbal, Randomized Controlled Trials as Topic |
| الوصف: | Background As the use of Chinese herbal medicine (CHM) in the international market increases, the number of clinical studies including randomized controlled trials (RCTs) of CHM which published in international journals has also increased. Using bibliometrics, we systematically and comprehensively analyzed the research status of CHM RCTs published in English during the period of 2010 to 2019. Methods Electronic searches in MEDLINE, EMBASE, and Cochrane Library databases were undertaken. CHM RCTs published in English between January 2010 and December 2019 were included. We randomly selected 20% from the eligible articles. Descriptive statistical analysis was carried out by extracting information on general information, characteristics of the study participants, interventions, outcomes, and risk of bias assessment of included RCTs. Results Two hundred and twenty-seven CHM RCTs published in English were included in our study. Chinese Journal of Integrative Medicine was the journal which published most of the relevant papers (22.0%). A total of 45,774 participants were included, sample size ranged from 12 to 3,143 (median: 115). The most common disease was the circulatory diseases (n=36, 15.9%). Decoction was the most common dosage form (28.2%), and "CHM vs. placebo" was the most common type of control (36.1%). The median of the total number of outcomes was 4 (range: 1-14), 92 (40.5%) did not clearly specify any primary outcome, 56 (24.7%) did not report any adverse event, 41 (18.1%) and 68 (30.0%) reported traditional Chinese medicine (TCM)- specific outcomes and quality of life, respectively. Eighty-five (37.4%) did not report sufficient information about the random sequence generation process, 100 (44.1%) used the adequate allocation concealment, 92 (40.5%) blinded participants and key study personnel, and 24 (10.6%) blinded outcome assessors. Conclusions Our results provided insight into the research status regarding CHM RCTs published in English during the past decade, this study may be helpful in understanding research trends in this field. |
| تدمد: | 2224-5839 2224-5820 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73386141c0c697ca89e16a91f09f7c7f https://doi.org/10.21037/apm-20-1033 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....73386141c0c697ca89e16a91f09f7c7f |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 22245839 22245820 |
|---|